Anxiolytic-like and sedative actions of Rollinia mucosa: possible involvement of the GABA/benzodiazepine receptor complex
| dc.contributor.affiliation | Instituto Nacional de Psiquiatría, México | es_ES |
| dc.contributor.email | marvaz@servidor.unam.mx | es_ES |
| dc.creator | Estrada-Reyes, Rosa | |
| dc.creator | López-Rubalcava, Carolina | |
| dc.creator | Rocha, Luisa | |
| dc.creator | Heinze, Gerardo | |
| dc.creator | González Esquinca, Alma Rosa | |
| dc.creator | Martínez-Vázquez, Mariano | |
| dc.creator.identificador | "EARR640516MMCSYS04">Estrada Reyes, Rosa | es_ES |
| dc.date.accessioned | 2017-06-30T01:39:27Z | |
| dc.date.accessioned | 2026-03-27T14:47:05Z | |
| dc.date.available | 2017-06-30T01:39:27Z | |
| dc.date.issued | 2010 | es_ES |
| dc.date.published | 2010 | es_ES |
| dc.description.abstractotrodioma | This study evaluated possible CNS effects of a hexane extract of leaves from Rollinia mucosa (Jacq.) Baill. (Annonaceae). This plant extract induced anxiolytic-like actions similar to those induced by diazepam in the avoidance exploratory behavior paradigm. Its significant activity was shown at doses from 1.62 to 6.25 mg/kg. It also enhanced pentobarbital-induced hypnosis time, and at high doses produced motor coordination impairment. The benzodiazepine (BDZ) receptor binding, evaluated by in vitro autoradiography following a single administration of R. mucosa, revealed that this plant extract reduced BDZ binding in the hippocampus (29%), amygdala (26%), and temporal cortex of mice (36%). In conclusion, the present findings support the proposal that R. mucosa may induce central nervous system (CNS) depressant effects, presumably through an interaction with the GABA/benzodiazepine receptor complex | es_ES |
| dc.description.month | Ene | es_ES |
| dc.identifier | 1506 | es_ES |
| dc.identifier.citation | Juan Carlos Bautista Ramírez | es_ES |
| dc.identifier.doi | 10.3109/13880200903046153 | es_ES |
| dc.identifier.eissn | 1744-5116 | es_ES |
| dc.identifier.issn | 1388-0209 | es_ES |
| dc.identifier.numero | 1 | es_ES |
| dc.identifier.organizacion | Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz | es_ES |
| dc.identifier.paginacion | 70-75 | es_ES |
| dc.identifier.place | Inglaterra | es_ES |
| dc.identifier.uri | https://doi.org/10.3109/13880200903046153 | es_ES |
| dc.identifier.uri | https://repositorio.inprf.gob.mx/handle/123456789/6185 | |
| dc.identifier.volumen | 48 | es_ES |
| dc.language.iso | eng | es_ES |
| dc.relation | 48 (1) 70-75 p. | es_ES |
| dc.relation | versión del editor | es_ES |
| dc.relation.jnabreviado | PHARM BIOL | es_ES |
| dc.relation.journal | Pharmaceutical Biology | es_ES |
| dc.rights | acceso cerrado | es_ES |
| dc.subject.ko | Animals | es_ES |
| dc.subject.ko | Anti-Anxiety Agents | es_ES |
| dc.subject.ko | isolation & purification | es_ES |
| dc.subject.ko | Anti-Anxiety Agents | es_ES |
| dc.subject.ko | pharmacology | es_ES |
| dc.subject.ko | Anti-Anxiety Agents | es_ES |
| dc.subject.ko | therapeutic use | es_ES |
| dc.subject.ko | Anxiety | es_ES |
| dc.subject.ko | drug therapy | es_ES |
| dc.subject.ko | Dose-Response Relationship, Drug | es_ES |
| dc.subject.ko | Drug Synergism | es_ES |
| dc.subject.ko | Exploratory Behavior | es_ES |
| dc.subject.ko | drug effects | es_ES |
| dc.subject.ko | Exploratory Behavior | es_ES |
| dc.subject.ko | physiology | es_ES |
| dc.subject.ko | Hypnotics and Sedatives | es_ES |
| dc.subject.ko | isolation & purification | es_ES |
| dc.subject.ko | Hypnotics and Sedatives | es_ES |
| dc.subject.ko | pharmacology | es_ES |
| dc.subject.ko | Hypnotics and Sedatives | es_ES |
| dc.subject.ko | therapeutic use | es_ES |
| dc.subject.ko | Male | es_ES |
| dc.subject.ko | Mice | es_ES |
| dc.subject.ko | Motor Activity | es_ES |
| dc.subject.ko | drug effects | es_ES |
| dc.subject.ko | Motor Activity | es_ES |
| dc.subject.ko | physiology | es_ES |
| dc.subject.ko | Pentobarbital | es_ES |
| dc.subject.ko | pharmacology | es_ES |
| dc.subject.ko | Pentobarbital | es_ES |
| dc.subject.ko | therapeutic use | es_ES |
| dc.subject.ko | Plant Extracts | es_ES |
| dc.subject.ko | isolation & purification | es_ES |
| dc.subject.ko | Plant Extracts | es_ES |
| dc.subject.ko | pharmacology | es_ES |
| dc.subject.ko | Plant Extracts | es_ES |
| dc.subject.ko | therapeutic use | es_ES |
| dc.subject.ko | Receptors, GABA | es_ES |
| dc.subject.ko | physiology | es_ES |
| dc.subject.ko | Receptors, GABA-A | es_ES |
| dc.subject.ko | physiology | es_ES |
| dc.subject.ko | Rollinia | es_ES |
| dc.subject.ko | Anti-Anxiety Agents | es_ES |
| dc.subject.ko | Hypnotics and Sedatives | es_ES |
| dc.subject.ko | Plant Extracts | es_ES |
| dc.subject.ko | Receptors, GABA | es_ES |
| dc.subject.ko | Receptors, GABA-A | es_ES |
| dc.subject.ko | Pentobarbital | es_ES |
| dc.title | Anxiolytic-like and sedative actions of Rollinia mucosa: possible involvement of the GABA/benzodiazepine receptor complex | es_ES |
| dc.type | article | es_ES |
